LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced that it has been awarded top honor as the “Most Promising Company” at the 2014 Personalized Medicine World Conference held in Mountain View, CA, January 27-28. T2 Biosystems was chosen from a group of 22 competitors in recognition of its strong business model and team, as well as its innovative T2MR technology. T2MR technology can be applied in the future to detect the presence of multiple diseases or conditions, including sepsis and trauma, and it powers the Company’s flagship T2Candida test, which is under investigation for the rapid detection of five species of Candida. The T2Candida test is designed to provide low limits of detection, (as low as 1 CFU/mL) and rapid results, typically in hours instead of days. T2Candida is currently in a pivotal clinical trial with results expected in the first half of 2014.
Help employers find you! Check out all the jobs and post your resume.
